The Entourage Effect: A Hypothesis, Not a Guarantee

Updated October 2026

If you shop for CBD, you’ve almost certainly seen the words “entourage effect.” It’s usually given as the reason to choose full-spectrum products: the idea that cannabis compounds work better together than alone.

It’s an interesting idea, and researchers take it seriously. It’s also an idea that is often sold as settled fact. This article explains where the term came from, what the research does and doesn’t show, and how to see what’s actually in a product.

Where the term came from

The phrase “entourage effect” was first used in 1998, and it wasn’t about cannabis plants at all. Researchers studying the body’s own endocannabinoid 2-AG found that some related fats in the body don’t bind to cannabinoid receptors themselves. Even so, they made 2-AG more active in lab and mouse tests.[1] The authors suggested this “entourage effect” could be one way the body fine-tunes its own cannabinoid signaling.[1]

Later, the idea was extended to the cannabis plant. The suggestion is that CBD, THC, minor cannabinoids and aromatic compounds called terpenes may work together. A widely cited 2011 review argued that terpenes “may contribute meaningfully” to the effects of cannabis extracts.[2] The same review was careful to say that this kind of synergy still had to be proven.[2]

What’s in the cannabis plant

Hemp and other cannabis plants contain many different compounds. These include:

• Cannabinoids such as CBD, THC, CBG (cannabigerol), CBC (cannabichromene) and CBN (cannabinol). Researchers have identified more than 100. Not all of them act on the body’s cannabinoid receptors, and having a pharmacological effect in a lab isn’t the same as having a proven health benefit.
• Terpenes such as myrcene, limonene, pinene and linalool. They give plants their smell, and they’re found in many everyday foods and plants too.
• Flavonoids and other plant compounds.

How much of each ends up in a finished product depends on the plant, the extraction and the processing. That’s why the label term alone doesn’t tell you much.

What the research shows so far

The evidence is mixed. Here is a fair summary.

Some findings are consistent with the idea. Cannabinoids can clearly affect one another in the body. For example, lab studies show CBD can change how the CB1 receptor responds to THC.[10]

Some findings cut against it. In a 2019 lab study, researchers tested six of the most common cannabis terpenes on human CB1 and CB2 receptors. None of them activated the receptors or changed how THC acted on them.[3] That doesn’t rule out effects elsewhere in the body. But it does undercut the popular claim that terpenes “boost” cannabinoid receptors.

“Working together” doesn’t always mean “better.” People often assume CBD softens THC. In a 2023 randomized trial, 18 healthy adults ate brownies with 20 mg of THC, either alone or with 640 mg of CBD.[5] With the added CBD, participants had stronger THC effects, including more anxiety, sedation and memory difficulty.[6] Researchers linked this to CBD slowing the body’s breakdown of THC.[6] Controlled studies have shown CBD can both weaken and strengthen THC’s effects, depending on the situation.[5] An interaction can be unwanted.

There’s no proven ranking of products. No head-to-head trials show that full-spectrum CBD products work better than broad-spectrum or isolate products. A 2020 critical review argued that entourage claims are “ill-defined” and often used mainly to sell products.[4] You don’t have to agree fully with that view to see the point. The entourage effect is a hypothesis being studied, not a product feature anyone can promise.

Full-spectrum, broad-spectrum and isolate

These terms describe what’s in an extract, not how well it works:

• Full-spectrum: contains CBD plus other cannabinoids naturally carried through from the plant. That includes a small amount of THC.
• Broad-spectrum: contains CBD and other cannabinoids, with THC removed or reduced to levels the lab doesn’t detect. Manufacturers make it in different ways.
• Isolate: CBD on its own. Our CBD Relaxation Tea is made with CBD isolate.

There’s a practical difference that matters more than any synergy claim: THC. In a study of a full-spectrum CBD oil taken daily for four weeks, 7 of 14 participants tested positive for a THC metabolite on a urine drug test.[7] If you’re drug tested, a full-spectrum product carries real risk. Even broad-spectrum and isolate products can’t guarantee a negative test. A lab report with THC listed as “ND” (not detected) applies to the batch tested, at that lab’s detection limit.

What’s in OnlyPure products

Rather than promise an effect, we’d rather show you the lab results. Our CBD Tincture and CBD Softgels are made with full-spectrum hemp extract. Here’s what two current reports show:

CBTC is cannabicitran, a minor cannabinoid. These reports measure cannabinoids. They don’t measure terpenes, so we can’t tell you which terpenes are in a given batch. Results also vary from batch to batch. You can find the report for every product on our Product COAs page. Check that the lot number matches your package.

Before you start

• Medications: The FDA warns that CBD can cause liver injury and can change how other medicines work.[8] Talk with your doctor first.
• Pregnancy and nursing: The FDA strongly advises against using CBD or THC in any form during pregnancy or while breastfeeding.[9]

Questions about a product or its lab report? Contact us or browse the OnlyPure shop.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

This article is general information, not medical advice. Talk to your doctor before using CBD if you take any medication, have a medical condition, or are pregnant or nursing. Not for use by anyone under 18.

Sources

1. Ben-Shabat S, Fride E, Sheskin T et al. “An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.” Eur J Pharmacol 1998;353(1):23-31 (PMID 9721036) — https://doi.org/10.1016/s0014-2999(98)00392-6 — HTTP 200 (resolves to the publisher)
2. Russo EB. “Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.” Br J Pharmacol 2011;163(7):1344-64 (PMID 21749363) — pmc.ncbi.nlm.nih.gov
3. Santiago M, Sachdev S, Arnold JC, McGregor IS, Connor M. “Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors.” Cannabis Cannabinoid Res 2019 (PMID 31559333; cell study) — pmc.ncbi.nlm.nih.gov
4. Cogan PS. “The ‘entourage effect’ or ‘hodge-podge hashish’: the questionable rebranding, marketing, and expectations of cannabis polypharmacy.” Expert Rev Clin Pharmacol 2020 (PMID 32116073; review/opinion) — https://pubmed.ncbi.nlm.nih.gov/32116073/ — HTTP 203 to curl (PubMed bot response; record identity confirmed via Europe PMC; publisher page returns 403 to curl)
5. Zamarripa CA et al. “Assessment of Orally Administered Δ9-THC When Coadministered With CBD…: A Randomized Clinical Trial.” JAMA Netw Open 2023;6(2):e2254752 — pmc.ncbi.nlm.nih.gov
6. NCCIH research summary — “When Taken Orally, Δ9-THC With Cannabidiol Can Result in Stronger Drug Effects Than Δ9-THC Alone” — www.nccih.nih.gov
7. Dahlgren MK et al. “Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical Trial.” JAMA Psychiatry 2021;78(3):335-337 — pmc.ncbi.nlm.nih.gov
8. FDA — What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD — www.fda.gov
9. FDA — What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding — www.fda.gov
10. Laprairie RB et al. “Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.” Br J Pharmacol 2015 (PMID 26218440; cell culture) — pmc.ncbi.nlm.nih.gov